Raymond J. Henley Iii

Array ( [id] => 3950391 [patent_doc_number] => 05955488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Freeze-dried compositions' [patent_app_type] => 1 [patent_app_number] => 9/066762 [patent_app_country] => US [patent_app_date] => 1998-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2133 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955488.pdf [firstpage_image] =>[orig_patent_app_number] => 066762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876819 [patent_doc_number] => 20010006972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SYMPTOMS OF IRRITABLE BOWEL SYNDROME' [patent_app_type] => new-utility [patent_app_number] => 09/063664 [patent_app_country] => US [patent_app_date] => 1998-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5176 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006972.pdf [firstpage_image] =>[orig_patent_app_number] => 09063664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4286406 [patent_doc_number] => 06180099 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Method of using immunoglobulin and fiber-containing compositions for human health' [patent_app_type] => 1 [patent_app_number] => 9/062204 [patent_app_country] => US [patent_app_date] => 1998-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 7516 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180099.pdf [firstpage_image] =>[orig_patent_app_number] => 062204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4049466 [patent_doc_number] => 05968973 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Method for treating hyperplasia' [patent_app_type] => 1 [patent_app_number] => 9/056378 [patent_app_country] => US [patent_app_date] => 1998-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2036 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968973.pdf [firstpage_image] =>[orig_patent_app_number] => 056378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3955958 [patent_doc_number] => 05935948 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Method of treating and preventing gallstones' [patent_app_type] => 1 [patent_app_number] => 9/056655 [patent_app_country] => US [patent_app_date] => 1998-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1546 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935948.pdf [firstpage_image] =>[orig_patent_app_number] => 056655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975853 [patent_doc_number] => 05958420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Treatment of burns, cuts, and abrasions of the skin' [patent_app_type] => 1 [patent_app_number] => 9/041923 [patent_app_country] => US [patent_app_date] => 1998-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 7362 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958420.pdf [firstpage_image] =>[orig_patent_app_number] => 041923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940000 [patent_doc_number] => 05981522 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Treatment of disease caused by infection of Helicobacter' [patent_app_type] => 1 [patent_app_number] => 9/041821 [patent_app_country] => US [patent_app_date] => 1998-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14514 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 303 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981522.pdf [firstpage_image] =>[orig_patent_app_number] => 041821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3987667 [patent_doc_number] => 05910502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-08 [patent_title] => 'Use of levobupivacaine in paediatric surgery' [patent_app_type] => 1 [patent_app_number] => 9/034070 [patent_app_country] => US [patent_app_date] => 1998-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2218 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/910/05910502.pdf [firstpage_image] =>[orig_patent_app_number] => 034070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103816 [patent_doc_number] => 06051566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation' [patent_app_type] => 1 [patent_app_number] => 9/032973 [patent_app_country] => US [patent_app_date] => 1998-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4452 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051566.pdf [firstpage_image] =>[orig_patent_app_number] => 032973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4147614 [patent_doc_number] => 06063799 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Alternate crystal form of Tazofelone' [patent_app_type] => 1 [patent_app_number] => 9/029205 [patent_app_country] => US [patent_app_date] => 1998-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3953 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063799.pdf [firstpage_image] =>[orig_patent_app_number] => 029205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950046 [patent_doc_number] => 05955466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea' [patent_app_type] => 1 [patent_app_number] => 9/028779 [patent_app_country] => US [patent_app_date] => 1998-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2158 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955466.pdf [firstpage_image] =>[orig_patent_app_number] => 028779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4108099 [patent_doc_number] => 06022877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Use of (+)-.alpha.-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl)ethyl]-4-piperidin emethanol in treating depressive disorders and bipolar disorders' [patent_app_type] => 1 [patent_app_number] => 9/026323 [patent_app_country] => US [patent_app_date] => 1998-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5889 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022877.pdf [firstpage_image] =>[orig_patent_app_number] => 026323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3927090 [patent_doc_number] => 05952393 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Composition for reducing serum cholesterol levels' [patent_app_type] => 1 [patent_app_number] => 9/022807 [patent_app_country] => US [patent_app_date] => 1998-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1406 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952393.pdf [firstpage_image] =>[orig_patent_app_number] => 022807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3970666 [patent_doc_number] => 05916566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds' [patent_app_type] => 1 [patent_app_number] => 8/973593 [patent_app_country] => US [patent_app_date] => 1998-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12954 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916566.pdf [firstpage_image] =>[orig_patent_app_number] => 973593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034372 [patent_doc_number] => 05942508 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid' [patent_app_type] => 1 [patent_app_number] => 9/017499 [patent_app_country] => US [patent_app_date] => 1998-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5610 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942508.pdf [firstpage_image] =>[orig_patent_app_number] => 017499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4043556 [patent_doc_number] => 05874422 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particulate pharmaceutical preparations' [patent_app_type] => 1 [patent_app_number] => 8/945857 [patent_app_country] => US [patent_app_date] => 1998-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1504 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874422.pdf [firstpage_image] =>[orig_patent_app_number] => 945857 [rel_patent_id] =>[rel_patent_doc_number] =>)